Agenda

Return

C. 63

To:	Board of Supervisors
From:	Anna Roth, Health Services Director
Date:	August 15, 2023

Contra

Costa

County

Subject:

Purchase Order with Becton Dickinson and Company

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 08/15/2023

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

John Gioia, District I Supervisor
John Gioia, District I Supervisor
Candace Andersen, District II Supervisor
Candace Andersen, District II Supervisor
Diane Burgis, District III Supervisor
Diane Burgis, District III Supervisor
Ken Carlson, District IV Supervisor
Ken Carlson, District IV Supervisor
Federal D. Glover, District V Supervisor
Federal D. Glover, District V Supervisor

Contact:

Karin Stryker, (925) 370-5141

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: August 15, 2023
Monica Nino, County Administrator

BY:	, Deputy

RECOMMENDATION(S):

APPROVE and AUTHORIZE the Purchasing Agent, or designee, to execute on behalf of the Health Services Director, a purchase order with Becton Dickinson and Company in an amount not to exceed $320,000 for the purchase of consumables, reagents, and supplies for Maldi and Phoenix equipment as needed for the Contra Costa Health (CCH) Contra Costa Regional Medical Center (CCRMC) for the period of September 1, 2023 through August 31, 2028.

FISCAL IMPACT:

Approval of this action will result in additional expenditures of up to $320,000 over a 5-year period and will be funded by Hospital Enterprise Fund I Revenues.

BACKGROUND:

The CCH CCRMC Clinical Laboratory uses Becton Dickinson and Company for supplies and reagents as needed for patient testing, including screening tests. Becton Dickinson and Company distributes necessary products for antimicrobial identification and susceptibility to help guide therapy and patient management decisions. The CCH CCRMC Clinical Laboratory has implemented the Maldi and Phoenix M50 analyzers, obtained via Purchase Order #28172, enabling faster turnaround times for patient results. Microbial identification and susceptibility are critical for clinicians for developing treatment protocols while timely resulting leads to more successful treatment outcomes.

The CCH CCRMC Clinical Laboratory has been doing business with Becton Dickinson Company for over 15 years due to their low prices and quality of service provided. Approval of the requested purchase order will allow Becton Dickinson and Company to providing the Clinical Laboratory the necessary consumables, reagents and supplies for patient testing through August 31, 2028.

CONSEQUENCE OF NEGATIVE ACTION:

If this action is not approved, the CCH CCRMC Clinical Laboratory will not be able to perform the specific patient testing which would negatively impact patient care.